41 related articles for article (PubMed ID: 31498561)
1. Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.
Aanei CM; Picot T; Tavernier E; Guyotat D; Campos Catafal L
Front Oncol; 2016; 6():161. PubMed ID: 27446807
[TBL] [Abstract][Full Text] [Related]
2. MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms.
Oelschlaegel U; Winter S; Sockel K; Epp K; Schadt J; Röhnert MA; Krüger T; Ruhnke L; Bornhäuser M; Platzbecker U; Kroschinsky F; von Bonin M
Leukemia; 2024 Feb; 38(2):446-450. PubMed ID: 38228682
[No Abstract] [Full Text] [Related]
3. Measurable (Minimal) Residual Disease in Myelodysplastic Neoplasms (MDS): Current State and Perspectives.
Zhang L; Deeb G; Deeb KK; Vale C; Peker Barclift D; Papadantonakis N
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672585
[TBL] [Abstract][Full Text] [Related]
4. Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms.
Dussiau C; Comont T; Knosp C; Vergnolle I; Bravetti C; Canali A; Houvert A; Largeaud L; Daveaux C; Zaroili L; Friedrich C; Boussaid I; Zalmai L; Almire C; Rauzy O; Willems L; Birsen R; Bouscary D; Fontenay M; Kosmider O; Chapuis N; Vergez F
Leukemia; 2024 May; 38(5):1131-1142. PubMed ID: 38575672
[TBL] [Abstract][Full Text] [Related]
5. Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood.
van der Pan K; de Bruin-Versteeg S; Damasceno D; Hernández-Delgado A; van der Sluijs-Gelling AJ; van den Bossche WBL; de Laat IF; Díez P; Naber BAE; Diks AM; Berkowska MA; de Mooij B; Groenland RJ; de Bie FJ; Khatri I; Kassem S; de Jager AL; Louis A; Almeida J; van Gaans-van den Brink JAM; Barkoff AM; He Q; Ferwerda G; Versteegen P; Berbers GAM; Orfao A; van Dongen JJM; Teodosio C
Front Immunol; 2022; 13():935879. PubMed ID: 36189252
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications.
Simoni Y; Chapuis N
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885563
[TBL] [Abstract][Full Text] [Related]
7. MRD abnormal expression predict poor outcomes for refractory or relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Hao Q; Liu X; Zhang Y; Zhang D; Li B; Wang J
J Clin Lab Anal; 2021 Oct; 35(10):e23974. PubMed ID: 34432318
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of multiparametric flow cytometry in diagnosis & prognosis of myelodysplastic syndrome in India.
Dhingra G; Dass J; Arya V; Gupta N; Saraf A; Langer S; Aggarwal S; Kotwal J; Bhargava M
Indian J Med Res; 2020 Sep; 152(3):254-262. PubMed ID: 33107485
[TBL] [Abstract][Full Text] [Related]
9. [The role of bone marrow cells immunophenotypic study by flow cytometry in diagnosing myelodysplastic syndrome].
Czyz A; Dworacki G; Komarnicki M
Postepy Hig Med Dosw (Online); 2008 Jul; 62():354-63. PubMed ID: 18688206
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1-tube panel strategy for diagnosis and prognosis of patients with MDS.
Barreau S; Green AS; Dussiau C; Alary AS; Raimbault A; Mathis S; Willems L; Bouscary D; Kosmider O; Bardet V; Fontenay M; Chapuis N
Cytometry B Clin Cytom; 2020 May; 98(3):226-237. PubMed ID: 31498561
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
[TBL] [Abstract][Full Text] [Related]
12. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Porwit A; Béné MC; Duetz C; Matarraz S; Oelschlaegel U; Westers TM; Wagner-Ballon O; Kordasti S; Valent P; Preijers F; Alhan C; Bellos F; Bettelheim P; Burbury K; Chapuis N; Cremers E; Della Porta MG; Dunlop A; Eidenschink-Brodersen L; Font P; Fontenay M; Hobo W; Ireland R; Johansson U; Loken MR; Ogata K; Orfao A; Psarra K; Saft L; Subira D; Te Marvelde J; Wells DA; van der Velden VHJ; Kern W; van de Loosdrecht AA
Cytometry B Clin Cytom; 2023 Jan; 104(1):27-50. PubMed ID: 36537621
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
